Heather L. Plasterer

Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease

Haiqun Jia, Judit Pallos, Vincent Jacques et al. · Neurobiology of Disease · 2012 · 160 citations · Full text

Chromatin, Chromatin Remodeling, Epigenetic Change +10

Chemical Probes Identify a Role for Histone Deacetylase 3 in Friedreich's Ataxia Gene Silencing

Chunping Xu, Elisabetta Soragni, C. James Chou et al. · Chemistry & Biology · 2009 · 116 citations · Full text

Histone Modifications, Chromatin, Histone Deacetylase 3 +12

Integrating multiple evidence sources to predict transcription factor binding in the human genome

Jason Ernst, Heather L. Plasterer, Itamar Simon et al. · Genome Research · 2010 · 100 citations · Full text

Engineering, Genetics, Transcriptomics Technology +23

The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models

Rocky G. Gogliotti, Herminio J. Cardona, J. J. Singh et al. · Human Molecular Genetics · 2013 · 87 citations · Full text

Cell Death, Cellular Physiology, Dcps Inhibitor Rg3039 +20

The DcpS inhibitor RG3039 improves motor function in SMA mice

James P. Van Meerbeke, Rebecca M. Gibbs, Heather L. Plasterer et al. · Human Molecular Genetics · 2013 · 68 citations · Full text

Motor Control, Cellular Physiology, Dcps Inhibitor Rg3039 +19